Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists-Reference-Cited by-同舟云学术

Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists

Published:2021-12-12 Issue:2 Volume:179 Page:287-300
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Denys Ian B.¹,Gao Juan¹,Sutphen Jane C.¹,Zaveri Nurulain T.²,Kapusta Daniel R.¹

Affiliation:

1. Department of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence Louisiana State University Health Sciences Center New Orleans Louisiana USA

2. Astraea Therapeutics, Medicinal Chemistry Division Mountain View California USA

Funder

National Institute on Drug Abuse

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15717

Reference31 articles.

1. The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors;Alexander S. P.;British Journal of Pharmacology,2021

2. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands

3. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

4. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

5. Rapid assessment of G protein signaling of four opioid receptors using a real-time fluorescence-based membrane potential assay

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing opportunities for chronic kidney disease;iScience;2024-06

2. Endogenous opiates and behavior: 2022;Peptides;2023-11